Increasing hippocampal acetylcholine levels enhance behavioral performance in an animal model of diencephalic amnesia

Brain Research

Volumn 1234, Issue , 2008, Pages 116-127

  Roland, Jessica J ^a   Mark, Katherine ^a   Vetreno, Ryan P ^a   Savage, Lisa M ^a  

^a BINGHAMTON UNIVERSITY   (United States)

Author keywords

Acetylcholine; Diencephalon; Hippocampus; Microdialysis; Rat; Spontaneous alternation

Indexed keywords

ACETYLCHOLINE; PHYSOSTIGMINE; PYRITHIAMINE;

ACETYLCHOLINE BRAIN LEVEL; AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIENCEPHALON; HIPPOCAMPUS; LEARNING DISORDER; LIMBIC SYSTEM; MALE; MEMORY DISORDER; MICRODIALYSIS; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; WERNICKE KORSAKOFF SYNDROME;

ACETYLCHOLINE; AMNESIA; ANIMALS; ANTIMETABOLITES; BEHAVIOR, ANIMAL; CHOLINESTERASE INHIBITORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COGNITION; DIENCEPHALON; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; KORSAKOFF SYNDROME; MALE; MICRODIALYSIS; PHYSOSTIGMINE; PSYCHOMOTOR PERFORMANCE; PYRITHIAMINE; RATS; RATS, SPRAGUE-DAWLEY; THIAMINE DEFICIENCY;

ANIMALIA; RATTUS; RODENTIA;

EID: 52049110725     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.07.090     Document Type: Article

References (97)

1. Aggleton J.P., and Brown M.W. Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behav. Brain Sci. 22 (1999) 425-489
2. Angunawela I.I., and Barker A. Anticholinesterase drugs for alcoholic Korsakoff syndrome. Int. J. Geriatr. Psychiatry 16 (2001) 337-339
3. Arendt T. Impairment in memory function and neurodegenerative changes in the cholinergic basal forebrain system induced by chronic intake of ethanol. J. Neural Transm. 44 (1994) 173-187
4. Barclay L.L., Gibson G.E., and Blass J.P. Impairment of behavior and acetylcholine metabolism in thiamine deficiency. J. Pharmacol. Exp. Ther. 217 (1978) 537-543
5. Barnes C.A., Meltzer J., Houston F., Orr G., McGann K., and Wenk G.L. Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience 99 (2000) 17-23
6. Beninger R.J., Wirsching B.A., Mallet P.E., Jhamandas K., and Boegman R.J. Physostigmine, but not 3,4-Diaminopyridine, improves radial maze performance in memory impaired rats. Pharmacol. Biochem. Behav. 51 (1995) 739-746
7. Bentivoglio M., Aggleton J.P., and Mishkin M. The thalamus and memory formation. In: Steriade M., Jones E.J., and McCormick D.A. (Eds). Thalamus (1997), Elsevier, Amsterdam 689-720
8. Braida D., and Sala M. Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies. CNS Drug Rev. 7 (2001) 369-386
9. Bunce J.G., Sabolek H.R., and Chrobak J.J. Intraseptal infusion of the cholinergic agonist carbachol impairs delayed-non-match-to-sample radial arm maze performance in the rat. Hippocampus 14 (2004) 450-459
10. Buzsaki G. Theta oscillations in the hippocampus. Neuron 33 (2002) 325-340
11. 3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin. Brain Res. 704 (1995) 153-166
12. Caulo M., Van Hecke L., Toma A., Ferretti A., Tartato A., Colosimo C., Romani G.L., and Uncini A. Functional MRI study of diencephalic amnesia in Wernicke-Korsakoff syndrome. Brain 128 (2005) 1584-1594
13. Chang Q., and Gold P.E. Impaired and spared cholinergic functions in the hippocampus after lesions of the medial septum/vertical limb of the diagonal band with 192 IgG-saporin. Hippocampus 14 (2004) 170-179
14. Cheney D.L., Gubler C.J., and Jaussi A. Production of acetylcholine in rat brain following thiamine deprivation and treatment with thiamine antagonists. J. Neurochem. 16 (1969) 1283-1291
15. Cochrane M., Cochrane A., Jauhar P., and Ashton E. Acetylcholinesterase inhibitors for the treatment of Wernicke-Korsakoff syndrome-three further cases show response to donepezil. Alcohol 40 (2005) 151-154
16. Colgin L.L., Kubota D., and Lynch G. Cholinergic plasticity in the hippocampus. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2872-2877
17. Colom L.V., Castaneda M.T., Reyna T., Hernandez S., and Garrido-Sanabria E. Characterization of medial septal glutamatergic neurons and their projection to the hippocampus. Synapse 58 (2005) 151-164
18. Cullen K.M., Halliday G.M., Caine D., and Kril J.J. The nucleus basalis (Ch4) in the alcoholic Wernicke-Korsakoff syndrome: reduced cell number in both amnesic and non-amnesic patients. J. Neurol. Neurosurg. Psychiatry 63 (1997) 315-320
19. Darreh-Shori T., Meurling L., Pettersson T., Hugosson K., Hellstrom-Lindahl E., Andreasen N., Minthon L., and Nordberg A. Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment. J. Neural Transm. 113 (2006) 1791-1801
20. Degroot A., and Parent M.B. Increasing acetylcholine levels in the hippocampus or entorhinal cortex reverses the impairing effects of septal GABA receptor activation on spontaneous alternation. Learn. Mem. 7 (2000) 293-302
21. Degroot A., and Parent M.B. Infusions of physostigmine into the hippocampus or entorhinal cortex attenuate avoidance retention deficits produced by intra-septal infusions of the GABA agonist muscimol. Brain Res. 920 (2001) 10-18
22. Dennes R.P., and Barnes J.C. Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze. Psychopharmacology 111 (1993) 435-441
23. Dokla C.P., and Thal L.J. Effect of cholinesterase inhibitors on Morris water task behavior following lesions of the nucleus basalis magnocellularis. Behav. Neurosci. 102 (1988) 861-871
24. Dong H., Csernansky C.A., Martin M.V., Bertchume A., Vallera D., and Csernansky J.G. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease. Psychopharmacology 181 (2005) 145-152
25. Dunnett S.B., and Martel F.L. Proactive interference effects on short-term memory in rats: I. Basic parameters and drug effects. Behav. Neurosci. 104 (1990) 655-665
26. Elvander E., Schott P.A., Sandin J., Bjelke B., Kehr J., Yoshitake T., and Ogren S.O. Intraseptal muscarinic ligands and galanin: influence on hippocampal acetylcholine and cognition. Neuroscience 126 (2004) 541-557
27. Fadel J., Sarter M., and Bruno J.P. Age-related attention of Stimulated cortical acetylcholine release in basal forebrain-lesioned rats. Neuroscience 90 (1999) 793-802
28. Flood J.F., Farr S.A., Uezu K., and Morley J.E. The pharmacology of post-trial memory processing in septum. Eur. J. Pharmacol. 350 (1998) 31-38
29. Frick K.M., Gorman L.K., and Markowska A.L. Oxotremorine infusions into the medial septal area of middle-aged rats affect spatial reference memory and ChAT activity. Behav. Brain Res. 80 (1996) 99-109
30. Givens B.S., and Olton D.S. Cholinergic and GABAergic modulation of medial septal area: effect on working memory. Behav. Neurosci. 104 (1990) 849-855
31. Gold P.E. Coordination of multiple memory systems. Neurobiol. Learn Mem. 82 (2004) 230-242
32. Hallak M., and Giacobini E. A comparison of the effects of two inhibitors on brain cholinesterase. Neuropharmacology 26 (1987) 521-530
33. Harding A., Halliday G., Caine D., and Kril J. Degeneration of anterior thalamic nuclei differentiates alcoholics with amnesia. Brain 123 (2000) 141-154
34. Harper C. Thiamine (vitamin B1) deficiency and associated brain damage is still common throughout the world and prevention is simple and safe!. Eur. J. Neurol. 13 (2006) 1078-1082
35. Hasselmo M.E. The role of acetylcholine in learning and memory. Curr. Opin. Neurobiol. 16 (2006) 1-6
36. Hasselmo M.E., and McGaughy J. High acetylcholine levels set circuit dynamics for attention and encoding and low acetylcholine levels set dynamics for consolidation. Prog Brain Res. 145 (2004) 207-231
37. Herremans A.H., Hijzen T.H., Olivier B., and Slangen J.L. Cholinergic drug effects on a delayed conditional discrimination task in the rat. Behav. Neurosci. 109 (1995) 426-435
38. Hoyumpa A.M. Mechanisms of thiamine deficiency in chronic alcoholism. Am. J. Clin. Nutr. 33 (1980) 2750-2761
39. Knapp M.J., Gracon S.I., Davis C.S., Solomon P.R., Pendlebury W.W., and Knopman D.S. Efficacy and safety of high-dose tacrine: a 30-week evaluation. Alzheimer Dis. Assoc. Disord. 8 (1994) 22-31
40. Kopelman M.D. The Korsakoff syndrome. Br. J. Psychiatry 166 (1995) 154-173
41. Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci. Biobehav. Rev. 26 (2002) 91-104
42. Langlais P.J., and Savage L.M. Thiamine deficiency in rats produces cognitive and memory deficits on spatial tasks, which correlate with tissue loss in diencephalon, cortex, and white matter. Behav. Brain Res. 68 (1995) 75-89
43. Langlais P.J., and Zhang S.X. Cortical and subcortical white matter damage without Wernicke's encephalopathy after recovery from thiamine deficiency in the rat. Alcohol., Clin. Exp. Res. 21 (1997) 434-443
44. Langlais P.J., Zhang S.X., and Savage L.M. Neuropathology of thiamine deficiency: an update on the comparative analysis of human disorders and experimental models. Metab. Brain Dis. 11 (1996) 19-37
45. Lawson V.H., and Bland B.H. The role of the septohippocampal pathway in the regulation of hippocampal field activity and behavior: analysis by the intraseptal microinfusion of carbachol, atropine, and procaine. Exp. Neurol. 120 (1993) 132-144
46. Lehmann O., Grottick A.J., Cassel J.-C., and Higgins G.A. A double dissociation between serial reaction time and radial maze performance in rats subjected to 192 IgG-saporin lesions of the nucleus basalis and/or the septal region. Eur. J. Neurosci. 18 (2003) 651-666
47. Levey A.I., Edmunds S.M., Hersch S.M., Wiley R.G., and Heilman C.J. Light and electron microscopic study of m2 muscarinic acetylcholine receptor in the basal forebrain of the rat. J. Comp. Neurol. 351 (1995) 339-356
48. Levey A.I., Edmunds S.M., Koliatsos V., Wiley R.G., and Heilman C.J. Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation. J. Neurosci. 15 (1995) 4077-4092
49. Mair R.G. On the role of thalamic pathology in diencephalic amnesia. Rev. Neurosci. 5 (1994) 105-140
50. Mair R.G., Otto T.A., Knoth R.L., Rabchenuk S.A., and Langlais P.J. Analysis of aversively conditioned learning and memory in rats recovered from pyrithiamine-induced thiamine deficiency. Behav. Neurosci. 105 (1991) 351-359
51. Markowska A.L., Olton D.S., and Givens B.S. Cholinergic manipulations in the medial septal area: age-related effects on working memory and hippocampal electrophysiology. J. Neurosci. 15 (1995) 2063-2073
52. Mitchell A.S., and Dalrymple-Alford J.C. Dissociable memory effects after medial thalamus lesions in the rat. Eur. J. Neurosci. 22 (2005) 973-985
53. Mohapel P., Leanza G., Kokaia M., and Lindvall O. Forebrain acetylcholine regulates adult hippocampal neurogenesis and learning. Neurobiol. Aging 26 (2005) 939-946
54. Moor E., DeBoer P., and Westerink B.H.C. GABA receptors and benzodiazepine binding sites modulate hippocampal acetylcholine release in vivo. Eur. J. Pharmacol. 359 (1998) 119-126
55. Moor E., DeBoer P., and Westerink B.H.C. Involvement of medial septal glutamate and GABAA receptors in behaviour-induced acetylcholine release in the hippocampus: a dual probe microdialysis study. Brain Res. 789 (1998) 1-8
56. Mulder J., Harkany T., Czollner K., Cremers T.I.F.H., Keijser J.N., Nyakas C., and Luiten P.G.M. Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum. Behavi Brain Res. 163 (2005) 33-41
57. Murray C.L., and Fibiger H.C. Learning and memory deficits after lesions of the nucleus basalis magnocellularis: reversal by physostigmine. Neuroscience 14 (1985) 1025-1032
58. Murray C.L., and Fibiger H.C. Pilocarpine and physostigmine attenuate spatial memory impairments produced by lesions of the nucleus basalis magnocellularis. Behav. Neurosci. 100 (1986) 23-32
59. Nakagawasai O. Behavioral and neurochemical alteration following thiamine deficiency in rodents: relationship to functions of cholinergic neurons. Pharm. Soc. Jpn. 125 (2005) 549-554
60. Nakagawasai O., Tadano T., Hozumi S., Tan-No K., Niijima F., and Kisara K. Immunohistochemical estimation of brain choline acetyltransferase and somatostatin related to the impairment of avoidance learning induced by thiamine deficiency. Brain Res. Bull. 52 (2000) 189-196
61. Nakagawasai O., Yamadera F., Iwasaki K., Arai H., Taniguchi R., Tan-No K., Sasaki H., and Tadano T. Effect of kami-untan-to on the impairment of learning and memory induced by thiamine-deficient feeding in mice. Neuroscience 125 (2004) 233-241
62. Olpe H.R., Klebs K., Küng E., Campiche P., Glatt A., Ortmann R., D'Amato F., and Pozza M.F. Mondadori C cholinomimetics induce theta rhythm and reduce hippocampal pyramidal cell excitability. Eur. J. Pharmacol. 14 (1987) 275-283
63. Ordy J.M., Thomas G.J., Volpe B.T., Dunlap W.P., and Colombo P.M. An animal model of human-type memory loss based on aging, lesion, forebrain ischemia, and drug studies with the rat. Neurobiol. Aging 9 (1988) 667-683
64. Pang K.C.H., and Nocera R. Interactions between 192-IgG saporin and intraseptal cholinergic and GABAergic drugs: role of cholinergic medial septal neurons in spatial working memory. Behav. Neurosci. 113 (1999) 265-275
65. Parent M.B., and Baxter M.G. Septohippocampal acetylcholine: involved in but not necessary for learning and memory?. Learn. Mem. 11 (2004) 9-20
66. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinate (1986), Academic Press, San Diego, CA
67. Pires R.G.W., Pereira S.R.C., Oliveira-Silva I.F., Franco G.C., and Ribeiro A.M. Cholinergic parameters and the retrieval of learned and re-learned spatial information: a study using a model of Wernicke-Korsakoff syndrome. Behav. Brain Res. 162 (2005) 11-21
68. Pitkin S.R., and Savage L.M. Aging potentiates the acute and chronic neurological symptoms of pyrithiamine-induced thiamine deficiency in the rodent. Behav. Brain Res. 119 (2001) 167-177
69. Pitkin S.R., and Savage L.M. Age-related vulnerability to diencephalic amnesia produced by thiamine deficiency: the role of time of insult. Behav. Brain Res. 148 (2004) 93-105
70. Ragozzino M.E., Wenk G.L., and Gold P.E. Glucose attenuates a morphine-induced decrease in hippocampal acetylcholine output: an in vivo microdialysis study in rats. Brain Res. 655 (1994) 77-82
71. Ragozzino M.E., Unick K.E., and Gold P.E. Hippocampal acetylcholine release during memory testing in rats: augmentation by glucose. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 4693-4698
72. Roland J.J., and Savage L.M. Blunted hippocampal, but not striatal, acetylcholine efflux parallels learning impairment in diencephalic-lesioned rats. Neurobiol. Learn Mem. 87 (2007) 123-132
73. Rowntree C.I., and Bland B.H. An analysis of cholinoceptive neurons in the hippocampal formation by direct microinfusion. Brain Res. 362 (1986) 98-113
74. Sabolek H.R., Bunce J.G., and Chrobak J.J. Intraseptal tacrine can enhance memory in cognitively impaired young rats. NeuroReport 15 (2004) 181-183
75. Sano M., Bell K., Marder K., Stricks L., Stern Y., and Mayeux R. Safety and efficacy of oral physostigmine in the treatment of Alzheimer's disease. Clin. Neuropharmacol. 16 (1993) 61-69
76. Savage L.M., Chang Q., and Gold P.E. Diencephalic damage decreases hippocampal acetylcholine release during spontaneous alternation testing. Learn. Mem. 10 (2003) 242-246
77. Savage L.M., Roland J.J., and Klintsova A. Selective septohippocampal - but not forebrain amygdalar - cholinergic dysfunction in diencephalic amnesia. Brain Res. 1139 (2007) 210-219
78. Shannon H.E., Bemis K.G., Hendrix J.C., and Ward J.S. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats. J. Pharmacol. Exp. Ther. 255 (1990) 1071-1077
79. Smith D.M., Freeman Jr. J.H., Nicholson D., and Gabriel M. Limbic thalamic lesions, appetitively motivated discrimination learning and training induced neuronal activity in rabbits. J. Neurosci. 15 (2002) 8212-8221
80. Somani S.M., Gupta S.K., Khalique A., and Unni L.K. Physiological pharmacokinetic and pharmacodynamic model of physostigmine in the rat. Drug Metabol. Dispos. 19 (1991) 660-665
81. Sotty F., Danik M., Manseau F., Laplante F., Quirion R., and Williams S. Distinct electrophysiological properties of glutamatergic, cholinergic and GABAergic rat septohippocampal neurons: novel implications for hippocampal rhythmicity. J. Physiol. 551 (2003) 927-943
82. Starke K., Gothert M., and Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physio. Rev. 69 (1989) 864-989
83. Stone W.S., Walser B., Gold S.D., and Gold P.E. Scopolamine- and morphine-induced impairments of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists. Behav. Neurosci. 105 (1991) 264-271
84. Todd K.G., and Butterworth R.F. Mechanisms of selective neuronal cell death due to thiamine deficiency. Ann. N.Y. Acad. Sci. (1999) 404-411
85. Tzavara E.T., Bymaster F.P., Felder C.C., Wade M., Gomeza J., Wess J., McKinzie D.L., and Nomikos G.G. Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice. Mol. Psychiatry 8 (2003) 673-679
86. Van der Welf Y.D., Witter M.P., and Groenewegen H.J. The intralaminar and midline nuclei of the thalamus: anatomical and functional evidence for participation in processes of arousal and awareness. Brain Res. Rev. 39 (2002) 107-140
87. Van der Zee E.A., and Luiten P.G.M. Cholinergic and GABAergic neurons in the rat medial septum express muscarinic acetylcholine receptors. Brain Res. 652 (1994) 263-272
88. Vertes R.P., Albo Z., and Viana Di Prisco G. Theta-rhythmically firing neurons in the anterior thalamus: implications for mnemonic functions of Papez's circuit. Neuroscience 104 (2001) 619-625
89. Victor M., and Martin J.B. Nutritional and metabolic diseases of the nervous system. In: Braunwald E. (Ed). Harrison's Principles of Internal Medicine. 13th ed. (1994), McGraw Hill Text, New York 2328-2331
90. Victor M., Adams R.D., and Collins G.H. The Wernicke-Korsakoff Syndrome. (1971), F.A. Davis, Philadelphia
91. Vilaro M.T., Wiederhold K.H., Palacios J.M., and Mengod G. Muscarinic M2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography. Neuroscience 47 (1992) 367-393
92. Vorhees C.V., Schmidt D.E., and Barrett R.J. Effects of pyrithiamine and oxythiamin on acetylcholine levels and utilization in rats brain. Brain Res. Bull. 3 (1978) 493-496
93. Vuckovich J.A., Semel M.E., and Baxter M.G. Extensive lesions of cholinergic basal forebrain neurons do not impair spatial working memory. Learn. Mem. 11 (2004) 87-94
94. Widmer H., Ferrigan L., Davies C.H., and Cobb S.R. Evoked slow muscarinic acetylcholinergic synaptic potentials in rat hippocampal interneurons. Hippocampus 16 (2006) 617-628
95. Wu M., Shanabrough M., Léránth C., and Alreja M. Cholinergic excitation of septohippocampal GABA but not cholinergic neurons: implications for learning and memory. J. Neurosci. 20 (2000) 3900-3908
96. Wu M., Newton S.S., Atkins J.B., Xu C., Dunman R.S., and Alreja M. Acetylcholinesterase inhibitors activate septohippocampal GABAergic neurons via muscarinic but not nicotinic receptors. J. Pharmacol. Exp. Ther. 307 (2003) 535-543
97. Yoder R.M., and Pang K.C. Involvement of GABAergic and cholinergic medial septal neurons in hippocampal theta rhythm. Hippocampus 15 (2005) 381-392